nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.371	1	CpDpCtD
Celecoxib—ALB—chronic obstructive pulmonary disease	0.165	1	CbGaD
Celecoxib—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0248	0.112	CbGbCtD
Celecoxib—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0248	0.112	CbGbCtD
Celecoxib—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0226	0.103	CbGbCtD
Celecoxib—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0226	0.103	CbGbCtD
Celecoxib—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0202	0.0915	CbGbCtD
Celecoxib—ALB—Prednisone—chronic obstructive pulmonary disease	0.0193	0.0875	CbGbCtD
Celecoxib—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.019	0.0862	CbGbCtD
Celecoxib—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0188	0.0851	CbGbCtD
Celecoxib—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0128	0.0582	CbGbCtD
Celecoxib—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0122	0.0555	CbGbCtD
Celecoxib—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0109	0.0495	CbGbCtD
Celecoxib—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0064	0.029	CbGbCtD
Celecoxib—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00604	0.0274	CbGbCtD
Celecoxib—PDPK1—respiratory system—chronic obstructive pulmonary disease	0.00257	0.116	CbGeAlD
Celecoxib—PTGS2—leg—chronic obstructive pulmonary disease	0.00159	0.0718	CbGeAlD
Celecoxib—Etoricoxib—CYP1A2—chronic obstructive pulmonary disease	0.00138	1	CrCbGaD
Celecoxib—MAPK14—respiratory system—chronic obstructive pulmonary disease	0.00137	0.062	CbGeAlD
Celecoxib—PDPK1—lung—chronic obstructive pulmonary disease	0.00136	0.0616	CbGeAlD
Celecoxib—MAPK14—connective tissue—chronic obstructive pulmonary disease	0.00121	0.0546	CbGeAlD
Celecoxib—MAPK14—bronchus—chronic obstructive pulmonary disease	0.00113	0.051	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—chronic obstructive pulmonary disease	0.00111	0.0499	CbGeAlD
Celecoxib—CA12—respiratory system—chronic obstructive pulmonary disease	0.00104	0.0471	CbGeAlD
Celecoxib—CA12—connective tissue—chronic obstructive pulmonary disease	0.000917	0.0414	CbGeAlD
Celecoxib—CA12—trachea—chronic obstructive pulmonary disease	0.00077	0.0348	CbGeAlD
Celecoxib—MAPK14—lung—chronic obstructive pulmonary disease	0.000729	0.0329	CbGeAlD
Celecoxib—CA4—respiratory system—chronic obstructive pulmonary disease	0.000645	0.0291	CbGeAlD
Celecoxib—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000577	0.0261	CbGeAlD
Celecoxib—CA12—lung—chronic obstructive pulmonary disease	0.000553	0.025	CbGeAlD
Celecoxib—CA2—respiratory system—chronic obstructive pulmonary disease	0.000535	0.0242	CbGeAlD
Celecoxib—CA5B—lung—chronic obstructive pulmonary disease	0.000496	0.0224	CbGeAlD
Celecoxib—CA4—trachea—chronic obstructive pulmonary disease	0.000477	0.0215	CbGeAlD
Celecoxib—CA2—connective tissue—chronic obstructive pulmonary disease	0.000471	0.0213	CbGeAlD
Celecoxib—CA2—bronchus—chronic obstructive pulmonary disease	0.00044	0.0199	CbGeAlD
Celecoxib—ORM1—lung—chronic obstructive pulmonary disease	0.000439	0.0198	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000431	0.0195	CbGeAlD
Celecoxib—CA2—trachea—chronic obstructive pulmonary disease	0.000395	0.0179	CbGeAlD
Celecoxib—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000395	0.0178	CbGeAlD
Celecoxib—ABCC4—lung—chronic obstructive pulmonary disease	0.000372	0.0168	CbGeAlD
Celecoxib—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000347	0.0157	CbGeAlD
Celecoxib—CA4—lung—chronic obstructive pulmonary disease	0.000342	0.0155	CbGeAlD
Celecoxib—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000325	0.0147	CbGeAlD
Celecoxib—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000318	0.0144	CbGeAlD
Celecoxib—PTGS2—trachea—chronic obstructive pulmonary disease	0.000292	0.0132	CbGeAlD
Celecoxib—CA2—lung—chronic obstructive pulmonary disease	0.000284	0.0128	CbGeAlD
Celecoxib—PTGS2—lung—chronic obstructive pulmonary disease	0.00021	0.00947	CbGeAlD
Celecoxib—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000881	CcSEcCtD
Celecoxib—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00088	CcSEcCtD
Celecoxib—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000873	CcSEcCtD
Celecoxib—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000873	CcSEcCtD
Celecoxib—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000873	CcSEcCtD
Celecoxib—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000873	CcSEcCtD
Celecoxib—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000872	CcSEcCtD
Celecoxib—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00087	CcSEcCtD
Celecoxib—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000867	CcSEcCtD
Celecoxib—Infection—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000867	CcSEcCtD
Celecoxib—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00086	CcSEcCtD
Celecoxib—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00086	CcSEcCtD
Celecoxib—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00086	CcSEcCtD
Celecoxib—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.000859	CcSEcCtD
Celecoxib—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000857	CcSEcCtD
Celecoxib—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000856	CcSEcCtD
Celecoxib—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000856	CcSEcCtD
Celecoxib—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.000855	CcSEcCtD
Celecoxib—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000855	CcSEcCtD
Celecoxib—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000855	CcSEcCtD
Celecoxib—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000852	CcSEcCtD
Celecoxib—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000852	CcSEcCtD
Celecoxib—Infection—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000849	CcSEcCtD
Celecoxib—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000848	CcSEcCtD
Celecoxib—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000848	CcSEcCtD
Celecoxib—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00012	0.000845	CcSEcCtD
Celecoxib—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000841	CcSEcCtD
Celecoxib—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000838	CcSEcCtD
Celecoxib—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000837	CcSEcCtD
Celecoxib—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000835	CcSEcCtD
Celecoxib—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00083	CcSEcCtD
Celecoxib—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000824	CcSEcCtD
Celecoxib—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000824	CcSEcCtD
Celecoxib—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000819	CcSEcCtD
Celecoxib—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000815	CcSEcCtD
Celecoxib—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.000811	CcSEcCtD
Celecoxib—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000811	CcSEcCtD
Celecoxib—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00081	CcSEcCtD
Celecoxib—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000808	CcSEcCtD
Celecoxib—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000807	CcSEcCtD
Celecoxib—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000804	CcSEcCtD
Celecoxib—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000803	CcSEcCtD
Celecoxib—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.0008	CcSEcCtD
Celecoxib—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.000797	CcSEcCtD
Celecoxib—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000797	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000795	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000795	CcSEcCtD
Celecoxib—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000789	CcSEcCtD
Celecoxib—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000789	CcSEcCtD
Celecoxib—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000785	CcSEcCtD
Celecoxib—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.000785	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000779	CcSEcCtD
Celecoxib—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000778	CcSEcCtD
Celecoxib—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000778	CcSEcCtD
Celecoxib—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000776	CcSEcCtD
Celecoxib—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000776	CcSEcCtD
Celecoxib—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000773	CcSEcCtD
Celecoxib—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00077	CcSEcCtD
Celecoxib—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000768	CcSEcCtD
Celecoxib—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000768	CcSEcCtD
Celecoxib—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000768	CcSEcCtD
Celecoxib—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.000765	CcSEcCtD
Celecoxib—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00076	CcSEcCtD
Celecoxib—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000108	0.000758	CcSEcCtD
Celecoxib—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000756	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000753	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000753	CcSEcCtD
Celecoxib—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000752	CcSEcCtD
Celecoxib—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000752	CcSEcCtD
Celecoxib—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000752	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000751	CcSEcCtD
Celecoxib—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000746	CcSEcCtD
Celecoxib—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000746	CcSEcCtD
Celecoxib—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000745	CcSEcCtD
Celecoxib—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000744	CcSEcCtD
Celecoxib—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00074	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000738	CcSEcCtD
Celecoxib—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000737	CcSEcCtD
Celecoxib—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000735	CcSEcCtD
Celecoxib—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000733	CcSEcCtD
Celecoxib—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00073	CcSEcCtD
Celecoxib—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000104	0.000729	CcSEcCtD
Celecoxib—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000726	CcSEcCtD
Celecoxib—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000726	CcSEcCtD
Celecoxib—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000725	CcSEcCtD
Celecoxib—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000723	CcSEcCtD
Celecoxib—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000722	CcSEcCtD
Celecoxib—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00072	CcSEcCtD
Celecoxib—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000719	CcSEcCtD
Celecoxib—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000719	CcSEcCtD
Celecoxib—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000102	0.000718	CcSEcCtD
Celecoxib—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000716	CcSEcCtD
Celecoxib—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000716	CcSEcCtD
Celecoxib—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000102	0.000715	CcSEcCtD
Celecoxib—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000714	CcSEcCtD
Celecoxib—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000714	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000711	CcSEcCtD
Celecoxib—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00071	CcSEcCtD
Celecoxib—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000705	CcSEcCtD
Celecoxib—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.96e-05	0.000699	CcSEcCtD
Celecoxib—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000699	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000699	CcSEcCtD
Celecoxib—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.88e-05	0.000693	CcSEcCtD
Celecoxib—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.88e-05	0.000693	CcSEcCtD
Celecoxib—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.83e-05	0.00069	CcSEcCtD
Celecoxib—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.83e-05	0.00069	CcSEcCtD
Celecoxib—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.83e-05	0.00069	CcSEcCtD
Celecoxib—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.83e-05	0.00069	CcSEcCtD
Celecoxib—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.8e-05	0.000688	CcSEcCtD
Celecoxib—Rash—Tiotropium—chronic obstructive pulmonary disease	9.72e-05	0.000682	CcSEcCtD
Celecoxib—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.71e-05	0.000681	CcSEcCtD
Celecoxib—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.71e-05	0.000681	CcSEcCtD
Celecoxib—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.68e-05	0.000679	CcSEcCtD
Celecoxib—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.68e-05	0.000679	CcSEcCtD
Celecoxib—Headache—Tiotropium—chronic obstructive pulmonary disease	9.66e-05	0.000677	CcSEcCtD
Celecoxib—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.63e-05	0.000676	CcSEcCtD
Celecoxib—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.63e-05	0.000676	CcSEcCtD
Celecoxib—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.000675	CcSEcCtD
Celecoxib—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.61e-05	0.000674	CcSEcCtD
Celecoxib—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	9.53e-05	0.000669	CcSEcCtD
Celecoxib—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	9.48e-05	0.000665	CcSEcCtD
Celecoxib—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.33e-05	0.000655	CcSEcCtD
Celecoxib—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	9.29e-05	0.000651	CcSEcCtD
Celecoxib—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	9.29e-05	0.000651	CcSEcCtD
Celecoxib—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.17e-05	0.000643	CcSEcCtD
Celecoxib—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.17e-05	0.000643	CcSEcCtD
Celecoxib—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.16e-05	0.000642	CcSEcCtD
Celecoxib—Dry skin—Prednisone—chronic obstructive pulmonary disease	9.13e-05	0.00064	CcSEcCtD
Celecoxib—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.000636	CcSEcCtD
Celecoxib—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.98e-05	0.00063	CcSEcCtD
Celecoxib—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.93e-05	0.000626	CcSEcCtD
Celecoxib—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.93e-05	0.000626	CcSEcCtD
Celecoxib—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.8e-05	0.000617	CcSEcCtD
Celecoxib—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.8e-05	0.000617	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000616	CcSEcCtD
Celecoxib—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.74e-05	0.000613	CcSEcCtD
Celecoxib—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.65e-05	0.000607	CcSEcCtD
Celecoxib—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.62e-05	0.000605	CcSEcCtD
Celecoxib—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.51e-05	0.000597	CcSEcCtD
Celecoxib—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.51e-05	0.000597	CcSEcCtD
Celecoxib—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.47e-05	0.000594	CcSEcCtD
Celecoxib—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000592	CcSEcCtD
Celecoxib—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.43e-05	0.000591	CcSEcCtD
Celecoxib—Sweating increased—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000588	CcSEcCtD
Celecoxib—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.34e-05	0.000585	CcSEcCtD
Celecoxib—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.31e-05	0.000583	CcSEcCtD
Celecoxib—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.23e-05	0.000577	CcSEcCtD
Celecoxib—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.23e-05	0.000577	CcSEcCtD
Celecoxib—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.06e-05	0.000565	CcSEcCtD
Celecoxib—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	8.04e-05	0.000564	CcSEcCtD
Celecoxib—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.91e-05	0.000555	CcSEcCtD
Celecoxib—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.91e-05	0.000555	CcSEcCtD
Celecoxib—Rash—Formoterol—chronic obstructive pulmonary disease	7.84e-05	0.00055	CcSEcCtD
Celecoxib—Rash—Arformoterol—chronic obstructive pulmonary disease	7.84e-05	0.00055	CcSEcCtD
Celecoxib—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.84e-05	0.00055	CcSEcCtD
Celecoxib—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.84e-05	0.00055	CcSEcCtD
Celecoxib—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.00055	CcSEcCtD
Celecoxib—Headache—Arformoterol—chronic obstructive pulmonary disease	7.79e-05	0.000547	CcSEcCtD
Celecoxib—Headache—Formoterol—chronic obstructive pulmonary disease	7.79e-05	0.000547	CcSEcCtD
Celecoxib—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.78e-05	0.000546	CcSEcCtD
Celecoxib—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.77e-05	0.000545	CcSEcCtD
Celecoxib—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000545	CcSEcCtD
Celecoxib—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.75e-05	0.000543	CcSEcCtD
Celecoxib—Rash—Montelukast—chronic obstructive pulmonary disease	7.68e-05	0.000539	CcSEcCtD
Celecoxib—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.68e-05	0.000538	CcSEcCtD
Celecoxib—Headache—Montelukast—chronic obstructive pulmonary disease	7.63e-05	0.000535	CcSEcCtD
Celecoxib—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000531	CcSEcCtD
Celecoxib—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.54e-05	0.000529	CcSEcCtD
Celecoxib—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000528	CcSEcCtD
Celecoxib—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000528	CcSEcCtD
Celecoxib—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.47e-05	0.000524	CcSEcCtD
Celecoxib—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.42e-05	0.00052	CcSEcCtD
Celecoxib—Rash—Salbutamol—chronic obstructive pulmonary disease	7.41e-05	0.00052	CcSEcCtD
Celecoxib—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.4e-05	0.000519	CcSEcCtD
Celecoxib—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.4e-05	0.000519	CcSEcCtD
Celecoxib—Nausea—Formoterol—chronic obstructive pulmonary disease	7.39e-05	0.000518	CcSEcCtD
Celecoxib—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.39e-05	0.000518	CcSEcCtD
Celecoxib—Headache—Salbutamol—chronic obstructive pulmonary disease	7.36e-05	0.000516	CcSEcCtD
Celecoxib—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.000509	CcSEcCtD
Celecoxib—Nausea—Montelukast—chronic obstructive pulmonary disease	7.24e-05	0.000508	CcSEcCtD
Celecoxib—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.13e-05	0.0005	CcSEcCtD
Celecoxib—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.98e-05	0.000489	CcSEcCtD
Celecoxib—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000486	CcSEcCtD
Celecoxib—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.89e-05	0.000483	CcSEcCtD
Celecoxib—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000481	CcSEcCtD
Celecoxib—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000475	CcSEcCtD
Celecoxib—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.74e-05	0.000473	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.74e-05	0.000473	CcSEcCtD
Celecoxib—Shock—Prednisolone—chronic obstructive pulmonary disease	6.63e-05	0.000465	CcSEcCtD
Celecoxib—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.58e-05	0.000461	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.51e-05	0.000457	CcSEcCtD
Celecoxib—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000452	CcSEcCtD
Celecoxib—Flushing—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000449	CcSEcCtD
Celecoxib—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000439	CcSEcCtD
Celecoxib—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000437	CcSEcCtD
Celecoxib—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000432	CcSEcCtD
Celecoxib—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.09e-05	0.000427	CcSEcCtD
Celecoxib—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000427	CcSEcCtD
Celecoxib—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.05e-05	0.000424	CcSEcCtD
Celecoxib—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000423	CcSEcCtD
Celecoxib—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000397	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.000389	CcSEcCtD
Celecoxib—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000389	CcSEcCtD
Celecoxib—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.000385	CcSEcCtD
Celecoxib—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.000378	CcSEcCtD
Celecoxib—Syncope—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000377	CcSEcCtD
Celecoxib—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.35e-05	0.000375	CcSEcCtD
Celecoxib—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.00037	CcSEcCtD
Celecoxib—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000363	CcSEcCtD
Celecoxib—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000358	CcSEcCtD
Celecoxib—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000358	CcSEcCtD
Celecoxib—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000357	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000356	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.96e-05	0.000348	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.9e-05	0.000343	CcSEcCtD
Celecoxib—Oedema—Prednisone—chronic obstructive pulmonary disease	4.9e-05	0.000343	CcSEcCtD
Celecoxib—Infection—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000341	CcSEcCtD
Celecoxib—Shock—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000338	CcSEcCtD
Celecoxib—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000337	CcSEcCtD
Celecoxib—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000335	CcSEcCtD
Celecoxib—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000334	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000332	CcSEcCtD
Celecoxib—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000327	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.46e-05	0.000313	CcSEcCtD
Celecoxib—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.46e-05	0.000313	CcSEcCtD
Celecoxib—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000311	CcSEcCtD
Celecoxib—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000308	CcSEcCtD
Celecoxib—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.000302	CcSEcCtD
Celecoxib—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.26e-05	0.000299	CcSEcCtD
Celecoxib—Rash—Prednisolone—chronic obstructive pulmonary disease	4.25e-05	0.000298	CcSEcCtD
Celecoxib—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.24e-05	0.000298	CcSEcCtD
Celecoxib—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000296	CcSEcCtD
Celecoxib—Headache—Prednisolone—chronic obstructive pulmonary disease	4.22e-05	0.000296	CcSEcCtD
Celecoxib—Constipation—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000294	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000283	CcSEcCtD
Celecoxib—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000281	CcSEcCtD
Celecoxib—Nausea—Prednisolone—chronic obstructive pulmonary disease	4e-05	0.000281	CcSEcCtD
Celecoxib—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000273	CcSEcCtD
Celecoxib—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000271	CcSEcCtD
Celecoxib—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000271	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000253	CcSEcCtD
Celecoxib—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.000246	CcSEcCtD
Celecoxib—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000243	CcSEcCtD
Celecoxib—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000235	CcSEcCtD
Celecoxib—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.000227	CcSEcCtD
Celecoxib—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.11e-05	0.000218	CcSEcCtD
Celecoxib—Rash—Prednisone—chronic obstructive pulmonary disease	3.09e-05	0.000217	CcSEcCtD
Celecoxib—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000216	CcSEcCtD
Celecoxib—Headache—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000215	CcSEcCtD
Celecoxib—Nausea—Prednisone—chronic obstructive pulmonary disease	2.91e-05	0.000204	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.28e-05	0.000293	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.27e-05	0.000291	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.27e-05	0.000291	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.26e-05	0.00029	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.25e-05	0.000289	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	2.25e-05	0.000289	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.24e-05	0.000287	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000286	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.22e-05	0.000285	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TLR4—chronic obstructive pulmonary disease	2.21e-05	0.000284	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.2e-05	0.000283	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.2e-05	0.000283	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.17e-05	0.000279	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.16e-05	0.000278	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	2.16e-05	0.000278	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.16e-05	0.000278	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.16e-05	0.000277	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.15e-05	0.000276	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.14e-05	0.000275	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.000274	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.12e-05	0.000272	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	2.11e-05	0.000271	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	2.11e-05	0.000271	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.09e-05	0.000269	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.08e-05	0.000267	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.08e-05	0.000267	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.08e-05	0.000267	CbGpPWpGaD
Celecoxib—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-05	0.000266	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.06e-05	0.000265	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.06e-05	0.000265	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000265	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CRP—chronic obstructive pulmonary disease	2.06e-05	0.000264	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000264	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	2.03e-05	0.000261	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—chronic obstructive pulmonary disease	2.03e-05	0.000261	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-05	0.00026	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.02e-05	0.000259	CbGpPWpGaD
Celecoxib—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.02e-05	0.000259	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.01e-05	0.000258	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—CTGF—chronic obstructive pulmonary disease	2e-05	0.000258	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2e-05	0.000257	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	2e-05	0.000257	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.99e-05	0.000255	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.000255	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TLR4—chronic obstructive pulmonary disease	1.97e-05	0.000253	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000253	CbGpPWpGaD
Celecoxib—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-05	0.000252	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.95e-05	0.000251	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS2—chronic obstructive pulmonary disease	1.94e-05	0.000249	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.93e-05	0.000248	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.91e-05	0.000246	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	1.88e-05	0.000242	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.88e-05	0.000242	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.88e-05	0.000241	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.87e-05	0.00024	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	1.87e-05	0.00024	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR2—chronic obstructive pulmonary disease	1.86e-05	0.000239	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000239	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.85e-05	0.000238	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	1.82e-05	0.000234	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.82e-05	0.000234	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000232	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.81e-05	0.000232	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.81e-05	0.000232	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000231	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.79e-05	0.00023	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.77e-05	0.000228	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.76e-05	0.000226	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—chronic obstructive pulmonary disease	1.75e-05	0.000225	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.75e-05	0.000225	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—chronic obstructive pulmonary disease	1.75e-05	0.000225	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KL—chronic obstructive pulmonary disease	1.75e-05	0.000224	CbGpPWpGaD
Celecoxib—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	1.75e-05	0.000224	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.73e-05	0.000222	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	1.71e-05	0.00022	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	1.71e-05	0.00022	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	1.71e-05	0.000219	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.000219	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.000216	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.68e-05	0.000216	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.000216	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.67e-05	0.000215	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.67e-05	0.000215	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.66e-05	0.000213	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000211	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.64e-05	0.00021	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.63e-05	0.00021	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.63e-05	0.000209	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000201	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS3—chronic obstructive pulmonary disease	1.56e-05	0.0002	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.54e-05	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	1.53e-05	0.000197	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.000195	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.51e-05	0.000194	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.000192	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.48e-05	0.00019	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.46e-05	0.000187	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	1.45e-05	0.000187	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.44e-05	0.000186	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.44e-05	0.000185	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—chronic obstructive pulmonary disease	1.44e-05	0.000185	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—chronic obstructive pulmonary disease	1.41e-05	0.000181	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.4e-05	0.00018	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000179	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.39e-05	0.000179	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	0.000178	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.38e-05	0.000177	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.38e-05	0.000177	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.37e-05	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.37e-05	0.000176	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.36e-05	0.000175	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.35e-05	0.000173	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.000172	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000171	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.32e-05	0.000169	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB3—chronic obstructive pulmonary disease	1.31e-05	0.000168	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000168	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.27e-05	0.000163	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.26e-05	0.000162	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	0.000161	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.24e-05	0.00016	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.23e-05	0.000158	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.21e-05	0.000156	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000156	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.21e-05	0.000155	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.21e-05	0.000155	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—chronic obstructive pulmonary disease	1.2e-05	0.000154	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.19e-05	0.000153	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000151	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.17e-05	0.00015	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR4—chronic obstructive pulmonary disease	1.15e-05	0.000147	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.13e-05	0.000145	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.13e-05	0.000145	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000145	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.11e-05	0.000143	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.11e-05	0.000142	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.11e-05	0.000142	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000142	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000142	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—chronic obstructive pulmonary disease	1.09e-05	0.000141	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.00014	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.00014	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.08e-05	0.000138	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.05e-05	0.000135	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.04e-05	0.000134	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.04e-05	0.000134	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—chronic obstructive pulmonary disease	1.03e-05	0.000132	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.03e-05	0.000132	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000131	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—chronic obstructive pulmonary disease	1.01e-05	0.00013	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.96e-06	0.000128	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.91e-06	0.000127	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—chronic obstructive pulmonary disease	9.77e-06	0.000126	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.68e-06	0.000124	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.31e-06	0.00012	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.21e-06	0.000118	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.18e-06	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	9.14e-06	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—chronic obstructive pulmonary disease	9.11e-06	0.000117	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.07e-06	0.000117	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.06e-06	0.000116	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.93e-06	0.000115	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	8.83e-06	0.000113	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.83e-06	0.000113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.76e-06	0.000113	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.65e-06	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.5e-06	0.000109	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.46e-06	0.000109	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—chronic obstructive pulmonary disease	8.41e-06	0.000108	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.21e-06	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.15e-06	0.000105	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	8.06e-06	0.000104	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.87e-06	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—chronic obstructive pulmonary disease	7.77e-06	9.98e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	7.72e-06	9.92e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.65e-06	9.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.57e-06	9.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.55e-06	9.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—chronic obstructive pulmonary disease	7.51e-06	9.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—chronic obstructive pulmonary disease	7.47e-06	9.6e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.42e-06	9.54e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.38e-06	9.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.31e-06	9.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.29e-06	9.37e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.23e-06	9.29e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.22e-06	9.28e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.08e-06	9.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.03e-06	9.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.74e-06	8.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.67e-06	8.57e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.65e-06	8.55e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.59e-06	8.47e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	6.44e-06	8.27e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.23e-06	8.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.19e-06	7.96e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.13e-06	7.88e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.11e-06	7.85e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.08e-06	7.81e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.94e-06	7.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.94e-06	7.64e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.72e-06	7.35e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.69e-06	7.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—chronic obstructive pulmonary disease	5.69e-06	7.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.67e-06	7.29e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.44e-06	6.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	5.42e-06	6.97e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.39e-06	6.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	5.18e-06	6.65e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.11e-06	6.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.07e-06	6.51e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.04e-06	6.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.03e-06	6.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5e-06	6.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.82e-06	6.2e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.77e-06	6.12e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	4.71e-06	6.05e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.7e-06	6.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.66e-06	5.98e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.55e-06	5.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	4.53e-06	5.82e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.45e-06	5.72e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.41e-06	5.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—chronic obstructive pulmonary disease	4.37e-06	5.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.35e-06	5.59e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.33e-06	5.57e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.09e-06	5.25e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.01e-06	5.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.75e-06	4.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.68e-06	4.73e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.51e-06	4.51e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	3.42e-06	4.4e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	3.36e-06	4.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.34e-06	4.29e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.3e-06	4.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.09e-06	3.97e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.07e-06	3.95e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-06	3.89e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3e-06	3.86e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.91e-06	3.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	3.72e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-06	3.69e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.83e-06	3.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	2.58e-06	3.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.98e-06	2.54e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-06	2.43e-05	CbGpPWpGaD
